Novo Nordisk has announced the initial results of the Diabetes Attitudes, Wishes and Needs 2 (DAWN2) study. The DAWN2 study is the largest study of its kind, conducted across 17 countries and 4 continents, into the psychosocial aspects of management of diabetes.